
OPERATIONAL REVIEW
HOME AND PERSONAL CARE (HPC)
OVERVIEW
Overall revenue in HPC declined by 5% to R1,9 billion, primarily due to lower volumes in the pesticides segment within Home Care. This, together with a significant cost-push, resulted in operating income declining by 29% to R308 million.

Personal Care’s revenue increased by 4% to R672 million as a result of price inflation of 12%, offset by volume declines of 8%. Despite improved profitability in the second half, significant increases in ingredients and packaging costs, as well as an adverse product mix, resulted in operating income declining by 66% to R16 million.
Home Care was unable to recover from a poor start to the year as unfavourable weather conditions impacted category demand for pesticides. Revenue declined by 9% to R1,2 billion, due to 17% lower volumes, offset by price inflation of 8%. Lower volumes, together with higher raw material and packaging costs, resulted in operating income declining by 24% to R292 million.
-
Revenue
Down 5%
R1,9bn
2021: 2,0 billion
-
Operating income
Down 29%
R308m
2021: 433 million
-
Operating margin
16,6%
2021: 22,2%
- Price management to protect margin
- Continued focus on factory efficiencies
- Execution of key capex projects: warehouse upgrade and aerosol replacement project
- Successfully deliver innovation focusing on functional benefits